Gilead to charge governments $2,340 for Covid-19 treatment remdesivir
US drugmaker releases proposed pricing for one of most promising coronavirus medicines
Full Article
Gilead to charge governments $2,340 for Covid-19 treatment remdesivir
FT.com
0 shares
1 views
You might like
Related news coverage
Gilead Sciences Announces Price Tag For Coronavirus Drug Remdesivir
Newsy
Watch VideoThe maker of the COVID-19 drug remdesivir announced it's pricing its antiviral medication at $520 a dose for most U.S...
Advertisement
More coverage
Gilead's remdesivir could see $7 billion in annual sales on stockpiling boost: analyst
Gilead Sciences Inc's potential COVID-19 treatment, remdesivir, could bring in more than $7 billion in annual sales by 2022,..
Reuters India
Gilead's remdesivir could see $7 billion in annual sales on stockpiling boost – analyst
Gilead Sciences Inc's potential COVID-19 treatment, remdesivir, could bring in more than $7 billion in annual sales by 2022,..
Reuters India